Similar articles

• Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.

  Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ. Meijnen P, et al. Br J Surg. 2007 Aug;94(8):952-6. doi: 10.1002/bjs.5735. Br J Surg. 2007. PMID: 17440955
• Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

  Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Silverstein MJ, et al. Cancer. 1994 Feb 1;73(3):664-7. doi: 10.1002/1097-0142(19940201)73:3<664::aid-cncr2820730326>3.0.co;2-s. Cancer. 1994. PMID: 8299088
• Breast conservation therapy in the management of invasive and in situ carcinoma.

  Masko GB, Triedman SA, Brotman RL, Webber BM, Yu A. Masko GB, et al. R I Med. 1995 Sep;78(9):246-9. R I Med. 1995. PMID: 7579719 Review. No abstract available.
• Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.

  Intra M, Rotmensz N, Veronesi P, Colleoni M, Iodice S, Paganelli G, Viale G, Veronesi U. Intra M, et al. Ann Surg. 2008 Feb;247(2):315-9. doi: 10.1097/SLA.0b013e31815b446b. Ann Surg. 2008. PMID: 18216539
• [Breast-conserving surgery in breast cancer].

  Ruggiero R, Procaccini E, Freda F, Iovino F, Irlandese E, Gili S, Lo Schiavo F. Ruggiero R, et al. G Chir. 2005 Nov-Dec;26(11-12):449-52. G Chir. 2005. PMID: 16472427 Review. Italian.